Your solution would effectively ban non competes, since basically no company would consider the price worth it.
Is this bad? Non-competes truly make sense only for high-value positions, like CTOs and VPs. And in this case you absolutely can afford to pay them during the non-compete period.
That number seems wrong. A typical level-2 charger will run at or below 7kW.
The standard is 40 amps at 240V, so around 10kW. And yes, they ARE charging 300 trucks at the same time.
First there were driverless cars, which are the kind of technology that's easy to get to 90%, damn hard to get to 95%, and impossible to get to 100%, but we all saw the predictions that driverless cars were only 5 years away... what... 10 years ago?
They actually were pretty on-point, with the first driverless taxies being launched in Arizona around 2019. And now you can get fully driverless Waymo taxies in SF.
The analyses posted completely ignore the 2022 Hunga Tonga volcanic eruption, which increased the amount of the greenhouse gas water-vapor in the stratosphere
But somehow it has not emitted any sulfur dioxide?
Ada users are mainly rolling their eyes at the Rust fad.
Ada's security guarantees were mainly for static programs. It didn't support anything reasonable for dynamic memory. They finally added it a couple of years ago, by adopting Rust's model of borrowing and scopes.
It depends on why it works on parasites. A lot of these idiots think it works on covid due to the mechanism behind ivermectin being a proteinase (enzyme) inhibitor
Ivermectin is NOT a protease inhibitor. It's a neurotoxic poison that interferes with GABA signaling in parasites. At higher concentrations it first starts to interfere with human GABA receptors, and if you keep cranking it up, it eventually starts binding with nuclear proteins. At this stage, it also affects the COVID virus.
However, looking at the pubmed NIH site for papers on ivermectin, there's a lot of research using treating it for a lot of things.
That's because researchers routinely test already approved drugs (there are around 20000 of them) as experimental treatments for different diseases. That's exactly what happened with ivermectin - it has shown activity against COVID viruses in a Petri dish. However, that was at concentrations that also would kill the patient.
Researchers then tried lower concentrations of ivermectin, and they found zero effect on COVID.
What would be interesting is if there were "moderation companies" and users could apply the moderation from the company they want.
That's exactly what AT protocol from Bluesky is about! It allows distributed moderation.
Eureka! -- Archimedes